Sakai

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia4 trials
• Chronic spontaneous urticaria3 trials
• Myelodysplastic syndromes2 trials
• Acute lymphoblastic leukaemia1 trial
• Aplastic anaemia1 trial
• Childhood cancers1 trial
• Diabetic eye disease1 trial
• Diffuse large B-cell lymphoma1 trial
• Multiple sclerosis1 trial
• Neuroendocrine tumours1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 37 trials
• Phase 22 trials

Status

• Completed7 trials
• Active, not recruiting4 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Novartis Pharmaceuticals14 trials

Running trials

• Recruiting

  Revolade Tablets Specified Drug-use Survey

  NCT06287268· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

  NCT05677451· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

  NCT05513001· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

  NCT04971226· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

  NCT04797000· Phase 2· Novartis Pharmaceuticals· Source

• Recruiting

  Study of Out of Specification for Tisagenlecleucel

  NCT04094311· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Aplastic anaemia1 recruiting
• Childhood cancers1 recruiting
• Diffuse large B-cell lymphoma1 recruiting

Closed trials

• Completed

  Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

  NCT05526729· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP

  NCT05215561· Novartis Pharmaceuticals· Source

• Completed

  A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

  NCT05048342· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  LUTATHERA Injection General Use Result Survey

  NCT05844332· Novartis Pharmaceuticals· Source

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Novartis Pharmaceuticals· Source

• Terminated

  Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)

  NCT04266301· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

  NCT03106779· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

  NCT01784068· Phase 2· Novartis Pharmaceuticals· Source